Arlington Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
317
+118
+59% +$56.6K 0.01% 140
2026
Q1
$97.8K Buy
199
+67
+51% +$36.4K 0.01% 163
2025
Q4
$76.5K Sell
132
-9
-6% -$5.09K 0.01% 164
2025
Q3
$68.4K Sell
141
-2
-1% -$931 0.01% 322
2025
Q2
$58K Buy
143
+2
+1% +$836 0.01% 339
2025
Q1
$70.2K Hold
141
0.01% 314
2024
Q4
$73.4K Hold
141
0.02% 307
2024
Q3
$87.2K Hold
141
0.02% 276
2024
Q2
$78K Hold
141
0.02% 284
2024
Q1
$82K Sell
141
-43
-23% -$24.1K 0.02% 239
2023
Q4
$97.7K Sell
184
-5,400
-97% -$2.61M 0.03% 218
2023
Q3
$2.83M Buy
+5,584
New +$2.98M 1.16% 28

Other funds holding TMO

Arlington Trust's TMO Position: Q2 2026 in Review

Arlington Trust increased its Thermo Fisher Scientific (TMO) stake by 59% in Q2 2026, buying an estimated $56.6K and bringing the position to 317 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #140.

Arlington Trust first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.83M in Q3 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Arlington Trust held 317 shares of Thermo Fisher Scientific worth $159K as of Q2 2026.
  • Arlington Trust bought 118 Thermo Fisher Scientific shares in Q2 2026, an estimated $56.6K.
  • Thermo Fisher Scientific made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #140 holding.
  • Arlington Trust first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Thermo Fisher Scientific position peaked at $2.83M in Q3 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.